OSTEOSHIELD DIN 02241450
Status: Cancelled (Unreturned Annual)
Holder: VINCO INC.
Health Canada record
| Active ingredient(s) | CALCIUM (CALCIUM HVP CHELATE, CALCIUM PHOSPHATE (TRIBASIC), CALCIUM CITRATE) 400 MG; VITAMIN D3 150 UNIT; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 1 MG; MAGNESIUM (MAGNESIUM HVP CHELATE, MAGNESIUM CITRATE) 167 MG; COPPER (COPPER HVP CHELATE) 1 MG; MANGANESE (MANGANESE HVP CHELATE) 1 MG; SILICON (SILICON HVP CHELATE) 1 MG; VANADIUM (VANADIUM HVP CHELATE) 25 MCG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | A11JB VITAMINS WITH MINERALS |
| Original market date | |
| Current status date | 05-Mar-2018 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Request a quote for OSTEOSHIELD